Clinical Trials Browser

Withdrawn × Colorectal Neoplasms × HMPL-013 × Clear all

NCT05690035 2024-07-09

Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms